At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several vaccines but did not vote on the influenza vaccine, as had previously been scheduled.

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a vaccine against respiratory syncytial virus.

The U.S. Centers for Disease Control and Prevention's panel of outside experts on Wednesday recommended the use of respiratory syncytial virus vaccines in younger adults who are at increased risk of severe illness from the virus.